ClinicalTrials.gg
Drug

Tipranavir clinical trials

studies test it
34
open now
0
in phase 3
7
first study started
1999

How each study uses tipranavir is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
22 Jun 2005 · APTIVUS · NDA 021814 (FDA, Drugs@FDA)
European Union
25 Oct 2005 · Aptivus · EMEA/H/C/000631 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Tipranavir
21
Tipranavir (TPV)
4

Brand

APTIVUS®
1

In one entry with another drug

Given together, or one or the other

Tipranavir/Ritonavir
2

Studies by the year they started

34 studies that test it; most in 2003 (9)

Studies that test tipranavir, by start year
YearStudies
19991
20011
20022
20039
20041
20056
20065
20077
20082

By phase

A phase 1/2 study counts in both.

Phase 1
21
Phase 2
6
Phase 3
7
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 29 · Other 5

Boehringer Ingelheim (29) · Germans Trias i Pujol Hospital (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Yale University (1) · Johns Hopkins University (1)

Often tested with

Tested in the same studies.

Ritonavir (22) · Saquinavir (2) · Darunavir (2) · Efavirenz (2) · Atazanavir (2) · Interferons (1) · Ribavirin (1) · Amprenavir (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses tipranavir is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 34

See all 34 studies that test tipranavir →

Given beside what is tested · 2 — tipranavir is usual care or a partner of the new treatment

Codes

What other systems call tipranavir · ClinicalTrials.gg INT004004

  • MeSH (NLM) C107201tipranavirConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) ZZT404XD09TIPRANAVIRConfirmed FDA, NLM, Wikidata
  • RxNorm 190548Confirmed FDA, Wikidata
  • Wikidata Q423404tipranavirConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66603TipranavirOne source FDA
  • DrugBank DB00932One source Wikidata

Also registered as (2r)-3,6-dihydro-6-oxo-2-(2-phenylethyl)-2-propyl-5-((1r)-1-(3-(((5-(trifluoromethyl)-2-pyridinyl)sulfonyl)amino)phenyl)propyl)-2h-pyran-4-yl .beta.-d-glucopyranosiduronic acid (UNII AAY9UHT656), tipranavir c-14 (UNII VU8T5RB4VW) and tipranavir disodium (UNII 9BAN2XG1ZW).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.